Selected Publications
Dinh PC Jr, Monahan PO, Fung C, Sesso HD, Feldman DR, Vaughn DJ, Hamilton RJ, Huddart R, Martin NE, Kollmannsberger C, Althouse S, Einhorn LH, Frisina R, Root JC, Ahles TA, Travis LB: Cognitive function in long-term testicular cancer survivors: impact of modifiable factors Journal of the National Cancer Institute Cancer Spectrum : 2024.
de Wit R, Vaughn DJ, Fradet Y, Fong L, Climent MA, Necchi A, Petrylak DP, Gerritsen WR, Gurney H, Quinn DI, Culine S, Sternberg CN, Bajorin DF, Choueiri TK, Xu J, Imai K, Homet Moreno B, Bellmunt J, Lee JL.: Impact of prior chemotherapy on response to second-line pembrolizumab in urothelial cancer: exploratory analysis of the phase 3 KEYNOTE-045 trial European Urology
: 2024.
Welch E, Guerraty MA, Demissei BG, Haas N, Takvorian S, Parikh RB, Vaughn DJ, Pryma D, Mankoff DA, Ky B, Narayan V: Coronary microvascular dysfunction in men with prostate cancer receiving androgen-deprivation therapy Clinical Genitourinary Cancer 22 (4): 2024.
Hsu M, Shan X, Zhang R, Berlin E, Goel A, Agarwal M, Wong YN, Christodouleas JP, Vaughn DJ, Narayan V, Takvorian SU, Vapiwala N, Pantel AR, Haas NB: Prostate cancer recurrence: examining the role of salvage radiotherapy field and risk factors for regional disease recurrence captured on 18F-DCFPyL PET/CT Clinical Genitourinary Cancer 22 (4): 2024.
Demissei BG, Ko K, Huang A, Lee DJ, Doucette AG, Smith AM, Wilcox NS, Reibel J, Sun L, Agarwal M, Haas NB, Hollis G, Shpilsky JE, Takvorian SU, Vaughn DJ, Chen J, Hubbard RA, Powell-Wiley T, Yancy C, Narayan V, Ky B: Social determinants of health mediate racial disparities in cardiovascular disease in men With prostate cancer Journal of the American College of Cardiology Cardio-Oncology
6 : 390-401,2024.
Dinh PC, Monahan PO, Fosså SD, Sesso HD, Feldman DR, Dolan ME, Nevel K, Kincaid J, Vaughn DJ, Martin NE, Sanchez VA, Einhorn LH, Frisina R, Fung C, Kroenke K, Travis LB: Impact of pain and adverse health outcomes on long-term U.S. testicular cancer survivors Journal of the National Cancer Institute
116 (3): 455-467,2024.
Bührer E, D'Haese D, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A, Hentrich M, Bokemeyer C, Negaard H, Fankhauser C, Shamash J, Vaughn DJ, Sternberg CN, Heidenreich A, Collette L, Gillessen S, Beyer J: Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium. European Journal of Cancer : 2024.
Lauritsen J, Sauvé N, Tryakin A, Jiang DM, Huddart R, Heng DYC, Terbuch A, Winquist E, Chovanec M, Hentrich M, Fankhauser CD, Shamash J, Del Muro XG, Vaughn D, Heidenreich A, Sternberg CN, Sweeney C, Necchi A, Bokemeyer C, Bandak M, Jandari A, Collette L, Gillessen S, Beyer J, Daugaard G.: Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
British Journal of Cancer 129 (11): 1759-1765,2023.
Pyle LC, Kim J, Bradfield J, Damrauer SM, D'Andrea K, Einhorn LH, Godse R, Hakonarson H, Kanetsky PA, Kember RL, Jacobs LA, Maxwell KN, Rader DJ, Vaughn DJ, Weathers B, Wubbenhorst B, Regeneron Genetics Center Research Team, Cancer Genomics Research Laboratory, Greene MH, Nathanson KL, Stewart DR: Germline exome sequencing for men with testicular germ cell tumor reveals coding defects in chromosomal segregation and protein-targeting genes European Urology 26 : S0302-2838,2023.
Maxwell R, Chang Y, Paul C, Vaughn DJ, Christodouleas JP: Cancer control, toxicity, and second malignancy risks of proton radiation therapy doe stage I-IIB testicular seminoma Advances in Radiation Oncology 8 (5): 101259,2023.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-114
3400 Civic Center Blvd
Philadelphia,
PA
19104-4283
Phone: 215-349-8140
Patient appointments: 800-789-7366